Nicole Scripsema, MD
Ophthalmology · Chicago, ILNPI 1386082261
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,885 of the $12,650 with a category attached, or 62.3%. 11 manufacturers reported payments, led by AbbVie at 56.0% of the total. Reporting peaked in 2021 at $6,953 and has fallen 99.7% since, to $19 in 2024. Among ophthalmology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 50 payments — averaging $253.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Genentech USA, Inc.$3K
- Regeneron$630
- Regeneron Healthcare Solutions, Inc.$350
- Novartis$249
- Genentech, Inc.$238
- plus $661 from 5 others
What the payments were for
- Consulting fees$7,88562%
- Travel & lodging$2,32618%
- Food & beverage$2,43919%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 28 | $7,089 |
| Genentech USA, Inc. | 5 | $3,433 |
| Regeneron | 2 | $630 |
| Regeneron Healthcare Solutions, Inc. | 4 | $350 |
| Novartis | 2 | $249 |
| Genentech, Inc. | 3 | $238 |
| Dutch Ophthalmic, USA | 1 | $183 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $165 |
| Spark Therapeutics, Inc. | 1 | $125 |
| Eyepoint US, Inc. | 1 | $124 |
| Amgen | 1 | $65 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,650 in reported general payments places this provider in the 90th percentile of 773 ophthalmology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 79 | $5,904 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 42 | $848 |
| Latanoprost | 37 | $484 |
| Ketorolac Tromethamine | 18 | $387 |
| Prednisone | 15 | $199 |
| Brimonidine Tartrate | 13 | $198 |
| MoxifloxacinMoxifloxacin Hcl | 19 | $180 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Chicago
- Seenu HariprasadChicago$2.3M
- Yannek LeidermanChicago$312K
- Asim FarooqChicago$270K
- Dilraj GrewalChicago$188K
- Ahmad ArefChicago$179K
- Robert SchroederChicago$153K
- Jennifer LimChicago$150K
- Surendra BastiChicago$126K
- Allen PuttermanChicago$94K
- Maria CortinaChicago$88K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.